Characterization of the HLA-restrictive elements of a rubella virus-specific cytotoxic T cell clone: Influence of HLA-DR4β chain residue 74 polymorphism on antigenic peptide-T cell interaction

International Immunology

Volumn 8, Issue 10, 1996, Pages 1577-1586

  Ou, Dawei ^a   Mitchell, Leslie Ann ^a   Domeier, Mary Ellen ^b   Tsang, Angela O W ^a   Décarie, Diane ^a   Tingle, Aubrey J ^a   Nepom, Gerald T ^b   Lacroix, Martial ^c   Zrein, Maan ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c BioChem Therapeutique Inc   (Canada)

Author keywords

HLA polymorphism; Rubella; T cell

Indexed keywords

HLA DR ANTIGEN;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CHROMIUM 51 RELEASE; CYTOTOXIC T LYMPHOCYTE; LYMPHOCYTE CLONE; PRIORITY JOURNAL; RUBELLA VIRUS;

AMINO ACID SEQUENCE; AMINO ACIDS; ANTIGENS, VIRAL; CLONE CELLS; HLA ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; RUBELLA VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029801767     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.10.1577     Document Type: Article

References (45)

1. Brown, J. H., Jardetzky, T., Saper, M. A., Samraoui, B., Bjorkman, P. J. and Wiley, D. C. 1988. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 332:845.
2. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
3. Marsh, S. G. E. and Bodmer, J. G. 1989. HLA-DR and DQ epitopes and monoclonal antibody specificity. Immunol. Today 10:305.
4. Marsh, S. G. E. and Bodmer, J. G. 1994. Gene registry: HLA class II region nucleotide sequences. Eur J. Immunol. 21:519.
5. Newton-Nash, D. K. and Eckels, D. D. 1993. Differential effect of polymorphism at HLA-DR1 β-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides. J. Immunol. 150:1813.
6. Fu, X-T., Bono, C. P., Woulfe, S. L., Swearingen, C., Summers, N. L., Sinigalia, F., Sette, A., Schwartz, B. D. and Karr, R. W. 1995. Pocket 4 of the HLA-DR (α,β1*0401) molecule is a major determinant of T cell recognition of peptide. J. Exp. Med. 181:915.
7. Jorgensen, J. L., Reay, P. A., Ehrich, E. W. and Davis, M. M. 1992. Molecular components of T-cell recognition. Annu. Rev. Immunol. 10:835.
8. Karr, R. W., Panina-Bordignon, P., Yu, W.-Y. and Lanzavecchia, A. 1991. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DRβ chain substitutions. J. Immunol. 146:4242.
9. Chicz, R. M., Urban, B. G., Gorga, J. C., Vignali, D. A. A., Lane, W. S. and Strominger, J. L. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
10. - cytotoxic T cell clones reactive to capsid antigen of rubella virus. Virology 191:680.
11. Ou, D., Mitchell, L. A., Ho, M., Décarie, D., Tingle, A. J., Nepom, G. T., Lacroix, M. and Zreir, M. 1994. Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein: influence of HLA-DR polymorphism of T-cell clonal recognition. Human Immunol. 39:177.
12. Ou, D., Chong, P., Tripet, B. and Gillam, S. 1992. Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptide. J. Virol. 66:1674.
13. Ou, D., Chong, P., Tingle, A. J. and Gillam, S. 1993. Mapping T-cell epitope of rubella virus structural proteins E1, E2 and C recognized by T-cell lines and clones derived from infected and immunized populations. J. Med. Virol. 40:175.
14. Hiraiwa, A., Yamanaka, K., Kwok, W. W., Mickelson, E. M., Masewicz, S., Hansen, J. A., Radka, S. F. and Nepom, G. T. 1990. Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. Proc. Natl Acad. Sci. USA 87:8051.
15. Kovats, S., Drover, S., Marshall, W. H., Freed, D., Whiteley, P. E., Nepom, G. T. and Blum, J. S. 1994. Coordinate defects in human histocompatibility leukocyte antigen class II expression and antigen presentation in Bare Lymphocyte Syndrome. J. Exp. Med. 179:2017.
16. + cytotoxic T-cell clones. J. Virol. 66:6788.
17. Busch, R., Strang, G., Howland, K. and Rothbard, J. B. 1990. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int. Immunol. 2:443.
18. Busch, R. and Rothbard, J. B. 1990. Detection of peptide-MHC class II complexes on the surface of intact cells. J. Immunol Methods 134:1.
19. Newton-Nash, D. K. and Eckels, D. D. 1992. Effects of Localized HLA class II β chain polymorphism on binding of antigenic peptide and stimulation of T cells. Human Immunol. 33:213.
20. Sherman, M. A., Runnels, H. A., Moore, J. C., Stern, L. J. and Jensen, P. E. 1994. Membrane interactions influence the peptide binding behavior of DR1. J. Exp. Med. 179:229.
21. Kwok, W. W., Nepom, G. T. and Raymond, F. C. 1995. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J. Immunol. 155:2468.
22. Lampson, L. A. and Levy, R. 1980. Two population of la-like molecules on a human B cell line. J. Immunol. 125:293.
23. Brodsky, F. M. and Parham, P. 1982. Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J. Immunol. 128:129.
24. Giles, R. C., Nunez, G., Hurley, C. K. and Nunez-Roldan, A. 1983. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J. Exp. Med. 157:1461.
25. Kupfer, A., Swain, S. L., Janeway, C. A., Jr and Singer, S. J. 1986. The specific direct interaction of helper T cells and antigen- presenting B cells. Proc. Natl Acad. Sci. USA 83:6080.
26. Ruppert, J., Alexander, J., Snoke, K., Coggeshall, M., Herbert, E., McKenzie, D., Grey, H. M. and Sette, A. 1993. Effect of T-cell receptor antagonism on interaction between T cells and antigen- presenting cells and on T-cell signaling events. Proc. Natl Acad. Sci. USA 90:2671.
27. Hume, C. R., Shookster, L. A., Collins, N., O'Reilly, R. and Lee, J. S. 1989. Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients. Human Immunol. 25:1.
28. Nepom, G. T., Domeier, M. E., Ou, D., Kovats, S., Mitchell, L. A. and Tingle, A. J. Recognition of contiguous allele-specific peptide elements in the rubella virus E1 envelope protein. Vaccines, in press.
29. Perfins, F. T. 1985. Licensed vaccines. Rev. Infect. Dis. 7:573.
30. Sandra, W. B., Stetler, H. C., Preblud, S. R., Williams, N. N., Orenstein, W. A., Bart, K. J., Hinman, A. R. and Herrmann, K. L. 1985. Fetal risk associated with rubella vaccine: an update. Rev. Infect. Dis. 7:S95.
31. Chantler, J. K., Ford, D. K. and Tingle, A. J. 1982. Persistent rubella infection and rubella-associated arthritis. Lancet i:1323.
32. Fraser, J. R. E., Cunningham, A. L., Hayes, K., Leach, R. and Lunt, R. 1983. Rubella arthritis in adults. Isolation of virus, cytology and other aspects of synovial reaction. Clin. Exp. Rheumatol. 1:287.
33. Busch, R., Hill, C. M., Hayball, J. D., Lamp, J. R. and Rothbard, J. B. 1991. Effect of natural polymorphism at residue 86 of the HLA-DR β chain on peptide binding. J. Immunol. 147:1292.
34. O'Sullivan, D., Arrhenius, T., Sidney, J., del Guercio, M. F., Albertson, M., Wall, M., Oseroff, C., Southwood, S., Colon, S. M., Gaeta, F. C. A. and Sette, A. 1991. On the interaction of promiscuous antigenic peptides with different DR alleles: identification of common structural motifs. J. Immunol. 147:2663.
35. O'Sullivan, D., Sidney, J., del Guercio, M. F., Colon, S. M. and Sette, A. 1991. Truncation analysis of several DR binding epitopes. J. Immunol. 146:1240.
36. 1 alleles. J. Immunol. 149:2634.
37. Sette, A., Sidney, J., Oseroff, C., del Guercio, M.-F., Southwood, S., Arrhenius, T., Powell, M. F., Colon, S. M., Gaeta, F. C. A. and Grey, H. M. 1993. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 151:3163.
38. Hill, C. M., Liu, A., Marshall, K. W., Mayer, J., Jorgensen, B., Yuan, B., Cubbon, R. M., Nichols, E. A., Wicker, L. S. and Rothbard, J. B. 1994. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 152:2890.
39. Malcherek, G., Gnau, V., Stevanovic, S., Rammensee, H.-G., Jung, G. and Melms, A. 1994. Analysis of allele-specific contact sites of natural HLA-DR17 ligands. J. Immunol. 153:1141.
40. Olson, R. R., Reuter, J. J., McNicholl, J., Alber, C., Klohe, E., Callahan, K., Siliano, R. F. and Karr, R. W. 1994. Acidic residues in the DRβ chain third hypervariable region are required for stimulation of a DR(α,β1*0402)-restricted T-cell clone. Human Immunol. 41:193.
41. Marshall, K. W., Liu, A. F., Canales, J., Perahia, B., Jorgensen, B., Gantzos, R. D., Aguilar, B., Devaux, B. and Rothbard, J. B. 1994. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J. Immunol. 152:4946.
42. Racioppi, L., Ronchese, F., Schwartz, R. H. and Germain, R. N. 1991. The molecular basis of class II MHC allelic control of T cell responses. J. Immunol. 147:3718.
43. Karr, R. W., Yu, W.-Y., Watts, R., Evans, K. S. and Celis, E. 1990. The role of polymorphic HLA-DRβ chain residues in presentation of antigen to T cells. J. Exp. Med. 172:273.
44. Winchester, R. 1994. The molecular basis of susceptibility to rheumatoid arthritis. Adv. Immunol. 56:389.
45. Nepom, G. T. and Ehrlich, H. 1991. MHC class II molecules and autoimmunity. Annu Rev. Immunol. 9:493.